Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

Concordance of Mutation Detection in Circulating Tumor DNA in Early Clinical Trials Using Different Blood Collection Protocols.

Ahlborn LB, Madsen M, Jonson L, Nielsen FC, Lassen U, Yde CW, Mau-Sorensen M.

Clin Lab. 2017 Oct 1;63(10):1755-1759. doi: 10.7754/Clin.Lab.2017.170516.

PMID:
29035458
2.

The Effect of Preservative and Temperature on the Analysis of Circulating Tumor DNA.

Parpart-Li S, Bartlett B, Popoli M, Adleff V, Tucker L, Steinberg R, Georgiadis A, Phallen J, Brahmer J, Azad N, Browner I, Laheru D, Velculescu VE, Sausen M, Diaz LA Jr.

Clin Cancer Res. 2017 May 15;23(10):2471-2477. doi: 10.1158/1078-0432.CCR-16-1691. Epub 2016 Nov 8.

3.

Effects of Collection and Processing Procedures on Plasma Circulating Cell-Free DNA from Cancer Patients.

Risberg B, Tsui DWY, Biggs H, Ruiz-Valdepenas Martin de Almagro A, Dawson SJ, Hodgkin C, Jones L, Parkinson C, Piskorz A, Marass F, Chandrananda D, Moore E, Morris J, Plagnol V, Rosenfeld N, Caldas C, Brenton JD, Gale D.

J Mol Diagn. 2018 Nov;20(6):883-892. doi: 10.1016/j.jmoldx.2018.07.005. Epub 2018 Aug 28.

4.

Comparative analysis of circulating tumor DNA stability In K3EDTA, Streck, and CellSave blood collection tubes.

Kang Q, Henry NL, Paoletti C, Jiang H, Vats P, Chinnaiyan AM, Hayes DF, Merajver SD, Rae JM, Tewari M.

Clin Biochem. 2016 Dec;49(18):1354-1360. doi: 10.1016/j.clinbiochem.2016.03.012. Epub 2016 Apr 27.

PMID:
27129799
5.

Performance of Streck cfDNA Blood Collection Tubes for Liquid Biopsy Testing.

Medina Diaz I, Nocon A, Mehnert DH, Fredebohm J, Diehl F, Holtrup F.

PLoS One. 2016 Nov 10;11(11):e0166354. doi: 10.1371/journal.pone.0166354. eCollection 2016.

6.

Liquid biopsy - Performance of the PAXgene® Blood ccfDNA Tubes for the isolation and characterization of cell-free plasma DNA from tumor patients.

Schmidt B, Reinicke D, Reindl I, Bork I, Wollschläger B, Lambrecht N, Fleischhacker M.

Clin Chim Acta. 2017 Jun;469:94-98. doi: 10.1016/j.cca.2017.03.031. Epub 2017 Mar 31. Erratum in: Clin Chim Acta. 2017 Jun;469:208.

PMID:
28373054
7.

Application of circulating tumor DNA in prospective clinical oncology trials - standardization of preanalytical conditions.

van Dessel LF, Beije N, Helmijr JC, Vitale SR, Kraan J, Look MP, de Wit R, Sleijfer S, Jansen MP, Martens JW, Lolkema MP.

Mol Oncol. 2017 Mar;11(3):295-304. doi: 10.1002/1878-0261.12037. Epub 2017 Feb 22.

8.

Comparison of Blood Collection Tubes from Three Different Manufacturers for the Collection of Cell-Free DNA for Liquid Biopsy Mutation Testing.

Alidousty C, Brandes D, Heydt C, Wagener S, Wittersheim M, Schäfer SC, Holz B, Merkelbach-Bruse S, Büttner R, Fassunke J, Schultheis AM.

J Mol Diagn. 2017 Sep;19(5):801-804. doi: 10.1016/j.jmoldx.2017.06.004. Epub 2017 Jul 18.

9.

Optimised Pre-Analytical Methods Improve KRAS Mutation Detection in Circulating Tumour DNA (ctDNA) from Patients with Non-Small Cell Lung Cancer (NSCLC).

Sherwood JL, Corcoran C, Brown H, Sharpe AD, Musilova M, Kohlmann A.

PLoS One. 2016 Feb 26;11(2):e0150197. doi: 10.1371/journal.pone.0150197. eCollection 2016.

10.

Evaluation of Streck BCT and PAXgene Stabilised Blood Collection Tubes for Cell-Free Circulating DNA Studies in Plasma.

Warton K, Yuwono NL, Cowley MJ, McCabe MJ, So A, Ford CE.

Mol Diagn Ther. 2017 Oct;21(5):563-570. doi: 10.1007/s40291-017-0284-x.

PMID:
28631163
11.

Comparison of cell stabilizing blood collection tubes for circulating plasma tumor DNA.

Toro PV, Erlanger B, Beaver JA, Cochran RL, VanDenBerg DA, Yakim E, Cravero K, Chu D, Zabransky DJ, Wong HY, Croessmann S, Parsons H, Hurley PJ, Lauring J, Park BH.

Clin Biochem. 2015 Oct;48(15):993-8. doi: 10.1016/j.clinbiochem.2015.07.097. Epub 2015 Jul 31.

12.

PIK3CA hotspot mutations in circulating tumor cells and paired circulating tumor DNA in breast cancer: a direct comparison study.

Tzanikou E, Markou A, Politaki E, Koutsopoulos A, Psyrri A, Mavroudis D, Georgoulias V, Lianidou E.

Mol Oncol. 2019 Dec;13(12):2515-2530. doi: 10.1002/1878-0261.12540. Epub 2019 Sep 30.

13.

Preanalytical blood sample workup for cell-free DNA analysis using Droplet Digital PCR for future molecular cancer diagnostics.

van Ginkel JH, van den Broek DA, van Kuik J, Linders D, de Weger R, Willems SM, Huibers MMH.

Cancer Med. 2017 Oct;6(10):2297-2307. doi: 10.1002/cam4.1184. Epub 2017 Sep 21.

14.

Enumeration and targeted analysis of KRAS, BRAF and PIK3CA mutations in CTCs captured by a label-free platform: Comparison to ctDNA and tissue in metastatic colorectal cancer.

Kidess-Sigal E, Liu HE, Triboulet MM, Che J, Ramani VC, Visser BC, Poultsides GA, Longacre TA, Marziali A, Vysotskaia V, Wiggin M, Heirich K, Hanft V, Keilholz U, Tinhofer I, Norton JA, Lee M, Sollier-Christen E, Jeffrey SS.

Oncotarget. 2016 Dec 20;7(51):85349-85364. doi: 10.18632/oncotarget.13350.

15.

Heterogeneous mutation pattern in tumor tissue and circulating tumor DNA warrants parallel NGS panel testing.

Guo Q, Wang J, Xiao J, Wang L, Hu X, Yu W, Song G, Lou J, Chen J.

Mol Cancer. 2018 Aug 28;17(1):131. doi: 10.1186/s12943-018-0875-0.

16.

Quantitative analysis of the BRAF V600E mutation in circulating tumor-derived DNA in melanoma patients using competitive allele-specific TaqMan PCR.

Ashida A, Sakaizawa K, Mikoshiba A, Uhara H, Okuyama R.

Int J Clin Oncol. 2016 Oct;21(5):981-988. Epub 2016 Apr 4.

PMID:
27041702
17.

Optimizing blood collection, transport and storage conditions for cell free DNA increases access to prenatal testing.

Wong D, Moturi S, Angkachatchai V, Mueller R, DeSantis G, van den Boom D, Ehrich M.

Clin Biochem. 2013 Aug;46(12):1099-1104. doi: 10.1016/j.clinbiochem.2013.04.023. Epub 2013 Apr 30.

18.

Use of circulating tumor cells in prospective clinical trials for NSCLC patients - standardization of the pre-analytical conditions.

Ilie M, Hofman V, Leroy S, Cohen C, Heeke S, Cattet F, Bence C, Lalvée S, Mouroux J, Marquette CH, Hofman P; STALKLUNG01 and AIR Study Consortium Investigators.

Clin Chem Lab Med. 2018 May 24;56(6):980-989. doi: 10.1515/cclm-2017-0764.

PMID:
29397019
19.

Circulating Tumor DNA Analysis in Patients With Cancer: American Society of Clinical Oncology and College of American Pathologists Joint Review.

Merker JD, Oxnard GR, Compton C, Diehn M, Hurley P, Lazar AJ, Lindeman N, Lockwood CM, Rai AJ, Schilsky RL, Tsimberidou AM, Vasalos P, Billman BL, Oliver TK, Bruinooge SS, Hayes DF, Turner NC.

J Clin Oncol. 2018 Jun 1;36(16):1631-1641. doi: 10.1200/JCO.2017.76.8671. Epub 2018 Mar 5. Review.

PMID:
29504847
20.

A new blood collection device minimizes cellular DNA release during sample storage and shipping when compared to a standard device.

Norton SE, Luna KK, Lechner JM, Qin J, Fernando MR.

J Clin Lab Anal. 2013 Jul;27(4):305-11. doi: 10.1002/jcla.21603.

Supplemental Content

Support Center